EICHORCondition: Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma of the Head and Neck · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
This trial will find out whether brentuximab vedotin and pembrolizumab work together to treat different types of cancer. There will be several different types of cancer studied in the trial. The cancer must have spread to other parts of the body (metastatic). The study will also find out what side effects occur. A side effect is anything the treatment does besides treat cancer. This is a multi-cohort study.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona Oncology Associates, PC - HOPE | Tucson, Arizona, United States | — |
| Arizona Oncology Associates, PC - HOPE | Tucson, Arizona, United States | — |
| Arizona Oncology Associates, PC - HOPE | Tucson, Arizona, United States | — |
| Highlands Oncology Group, PA | Fayetteville, Arkansas, United States | — |
| Highlands Oncology Group, PA | Rogers, Arkansas, United States | — |
| Highlands Oncology Group, PA | Springdale, Arkansas, United States | — |
| California Cancer Associates for Research and Excellence, Inc (cCARE) | Encinitas, California, United States | — |
| California Cancer Associates for Research and Excellence, Inc. cCARE | Fresno, California, United States | — |
| The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate | Los Angeles, California, United States | — |
| Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute (SOCCI) | Los Angeles, California, United States | — |
| California Cancer Associates for Research and Excellence Inc (cCARE) | San Marcos, California, United States | — |
| The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate (Emergency Back-Up Only) | Santa Monica, California, United States | — |
+ 78 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04609566